2008
DOI: 10.1097/moh.0b013e3282f30448
|View full text |Cite
|
Sign up to set email alerts
|

Wiskott-Aldrich syndrome

Abstract: Wiskott-Aldrich syndrome protein gene mutations result in four clinical phenotypes: classic Wiskott-Aldrich syndrome and X-linked thrombocytopenia, intermittent thrombocytopenia and neutropenia. Wiskott-Aldrich syndrome protein is a signaling molecule and instrumental for cognate and innate immunity, cell motility and protection against autoimmune disease. The success of hematopoietic stem cell transplantation is related to the recipient's age, donor selection, the conditioning regimen and the extent of recons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
130
0
7

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 176 publications
(138 citation statements)
references
References 60 publications
1
130
0
7
Order By: Relevance
“…Recent studies, however, have begun reporting novel biochemical activities for actin nucleators, including MT stabilization activity by mammalian Diaphanous (Bartolini et al, 2008;Palazzo et al, 2004), filopodia inhibition by WAVE/Arp2/3 (Stradal et al, 2004), and F-actin and MT bundling and crosslinking by Spire and Capu (Rosales-Nieves et al, 2006). Consistent with this, not all diseaseassociated WASP mutations are predicted to affect its actin-nucleation activity (Notarangelo et al, 2008). Our results contribute to this growing list of actin nucleators with significant non-nucleation activities, as we show that Wash is both an Arp2/3 activator and a crosslinker/bundler of F-actin and microtubules.…”
Section: Wash Function In Drosophila Oogenesissupporting
confidence: 65%
“…Recent studies, however, have begun reporting novel biochemical activities for actin nucleators, including MT stabilization activity by mammalian Diaphanous (Bartolini et al, 2008;Palazzo et al, 2004), filopodia inhibition by WAVE/Arp2/3 (Stradal et al, 2004), and F-actin and MT bundling and crosslinking by Spire and Capu (Rosales-Nieves et al, 2006). Consistent with this, not all diseaseassociated WASP mutations are predicted to affect its actin-nucleation activity (Notarangelo et al, 2008). Our results contribute to this growing list of actin nucleators with significant non-nucleation activities, as we show that Wash is both an Arp2/3 activator and a crosslinker/bundler of F-actin and microtubules.…”
Section: Wash Function In Drosophila Oogenesissupporting
confidence: 65%
“…Este fenotipo generalmente está adjudicado a una menor expresión de la WASp; 3) neutropenia ligada al cromosoma X, manifestada únicamente con inmunodeficiencia, y suele presentar una mutación de ganancia de función en el gen WAS; 4) trombocitopenia ligada al X intermitente, en la que se observan plaquetas pequeñas con o sin trombocitopenia y, en ocasiones, inmunodeficiencia. [4][5][6]10 Las manifestaciones clínicas que sugieren la presencia de WAS pueden presentarse desde el nacimiento e incluyen petequias, lesiones purpúricas y diarrea con presencia de sangre. Una orientación para el diagnóstico temprano de esta patología es la presencia de sangrado excesivo después de un evento quirúrgico, así como eczema.…”
Section: Discussionunclassified
“…It is associated with thrombocytopenia, severe eczema, and susceptibility to autoimmunity and malignancy. Affected males rarely survive beyond the second decade of life 19 . 21 .…”
Section: Wiskott-aldrich Syndrome (Was)mentioning
confidence: 99%